BioSpace News Archive

Deals

Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation

Avertix Medical, Inc. and BIOS Acquisition Corporation announced that the companies have entered into a definitive merger agreement for a business combination that would result in Avertix becoming a publicly traded company on Nasdaq.

May 3, 2023
·
13 min read
Business

Xenetic Biosciences, Inc. Adds Business Development Expertise with Appointment of Scott N. Cullison

Xenetic Biosciences, Inc. today announced it has engaged Scott N. Cullison to serve as an executive consultant for business development and to support the advancement of the Company’s DNase-based oncology platform.

May 3, 2023
·
6 min read
Business

QIAGEN exceeds outlook for Q1 2023 with 12% CER sales growth in non-COVID product portfolio

Net sales for Q1 2023 declined 23% to $485 million from Q1 2022, which was marked by very strong COVID-19 sales contributions.

May 3, 2023
·
7 min read
Business

OPKO Health Reports First Quarter 2023 Business Highlights and Financial ResultsConference call begins at 4:30 p.m. Eastern time today

OPKO Health, Inc. reports business highlights and financial results for the three months ended March 31, 2023.

May 3, 2023
·
9 min read
BioCapital

New ACR Breast Cancer Screening Guidelines call for earlier and more-intensive screening for high-risk women

New American College of Radiology® breast cancer screening guidelines now call for all women — particularly Black and Ashkenazi Jewish women — to have risk assessment by age 25 to determine if screening earlier than age 40 is needed.

May 3, 2023
·
3 min read
Biotech Bay

Amgen to Present at the 2023 Bank of America Merrill Lynch Global Healthcare Conference

Amgen will present at the 2023 Bank of America Merrill Lynch Global Healthcare Conference at 11:00 a.m. ET on Tuesday, May 9, 2023.

May 3, 2023
·
2 min read
BioMidwest

Zynex Announces Proposed Secondary Public Offering of Common Stock - May 03, 2023

Zynex, Inc., announced the commencement of an underwritten public offering of 2,000,000 shares of its common stock by Thomas Sandgaard, its Chief Executive Officer.

May 3, 2023
·
4 min read
Nanalysis Scientific Corp. Announces Closing of Second Tranche to Fully Complete its $4,128,700 Offering

Nanalysis Scientific Corp. is pleased to announce, further to its news releases dated April 21, 2023, April 26, 2023 and May 1, 2023, it has successfully closed the second and final tranche of its $4,128,700 non-brokered private placement.

May 3, 2023
·
5 min read
Business

10x Genomics Reports First Quarter 2023 Financial Results

10x Genomics, Inc. reported financial results for the first quarter ended March 31, 2023.

May 3, 2023
·
10 min read
Biotech Bay

PacBio to Present at BofA Securities 2023 Health Care Conference

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in the BofA Securities 2023 Health Care Conference in Las Vegas, Nevada.

May 3, 2023
·
1 min read